This article was generated by Benzinga's automated content engine and reviewed by an editor.

ProPhase Labs, Inc., a company specializing in pharmaceutical preparations with a current market capitalization of $8.16 million, has announced an executive shift with the departure of its current ...

专注于制药业务、目前市值816万美元的ProPhase Labs, Inc.宣布进行高管层变动，现任首席运营官 (COO) Jed Latkin即将离职，Stuart Hollenshead将接任新COO一职。此次人事变动紧随Pharmaloz Manufacturing, ...

Tivic Health Systems, Inc. TIVC rose 42% to $0.9937 in pre-market trading. Tivic Health Systems shares jumped 198% on ...

北京时间2025年02月12日03时33分，恩佐生化（ENZ.us）股票出现异动，股价快速下跌5.56%。截至发稿，该股报0.510美元/股，成交量26.0936万股， 换手率 0.50%，振幅8.98%。

万基遗传股票所在的生命科学行业中，整体跌幅为0.02%。其相关个股中，Grail, Inc.、Prophase Labs, Inc.、Exagen Inc.涨幅较大，Mainz Biomed N.V.、Genedx Holdings Corp.、Ispecimen Inc.较为活跃，换手率分别为17.40%、12.68%、3.83%，振幅较大的相关个股有Genedx Holdings Corp C ...

ProPhase Labs, Inc. Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company’s Balance Sheet and ...

Stock analysts at StockNews.com initiated coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Free Report) in a research ...

StockNews.com upgraded shares of Hawthorn Bancshares (NASDAQ:HWBK – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday. Hawthorn Bancshares Price ...